eptifibatide
Selected indexed studies
- Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke. (N Engl J Med, 2024) [PMID:39231343]
- Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice. (Int J Mol Sci, 2023) [PMID:36982519]
- Eptifibatide overdose. (Int J Cardiol, 2009) [PMID:18023892]
_Worker-drafted node — pending editorial review._
Connections
eptifibatide is a side effect of
Sources
- Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke. (2024) pubmed
- Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice. (2023) pubmed
- Eptifibatide overdose. (2009) pubmed
- Delayed-onset eptifibatide-induced thrombocytopenia. (2024) pubmed
- Eptifibatide as an adjuvant therapy to thrombolysis versus thrombolysis alone in stroke management: a systematic review and meta-analysis of randomized controlled trials. (2025) pubmed
- Eptifibatide-Induced Thrombocytopenia--When Inhibitor Turns Killer. (2016) pubmed
- Eptifibatide-associated acute, profound thrombocytopenia. (2005) pubmed
- Clinical pharmacology of eptifibatide. (1997) pubmed
- Development of eptifibatide. (1999) pubmed
- Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. (1999) pubmed